不能切除的肝细胞癌综合介入治疗初探

目的：评价综合介入（肝动脉化疗栓塞联合超声引导下介入）治疗不能手术切除的原发肝癌的疗效。方法：６２例不能手术切除的原发肝癌患者分为两组，Ａ组３１例行单纯ＴＡＣＥ，Ｂ组３１例行综合介入治疗，于ＴＡＣＥ治疗两周后再行超声引导下介入治疗。结果：本组病例全部随访１个月～２年。Ｂ组１年、２年的生存率分别为５８．０６％和３８．７１％，高于Ａ组的２２．５８％和９．６８％（均Ｐ〈０．０１）。结论：对于不能手术切除

Combinational lntervention Therapy of Unresectable Hepatocellular Carcinoma

To evaluate the effect of the combinational therapy of transcatheter arterial chemo-embolization (TACE) and ultra-sonography guided intervention on unresectable hepatocellular carcinoma (HCC). Methods: Sxty-two patients with unresectable HCC were divided into two groups at random. Group B( n = 31) was treated with combinational intervention therapy. After 2 weeks of TACE .ultrasonography guided intervention therapy was performed for several times. Group A (n = 31) was treated with TACE alone as control. Results: All cases were followed up for 6 months to 2 years. The 1-year and 2-year survival rates in group B (58.06% and 38.17%) were higher than those in group A (22.58% and 9.68%) (all P<0.01).Conclusion:For unresectable HCC,the effect of combinational intervention therapy significantly excels that of TACE alone.